Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation

NCT07271134 | Not Yet Recruiting DMC

• 2 other identifiers: WHZXKYL2025-123I-AS-25-105
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation

Conditions

Missing Teeth

Keywords

Short implant; Maxillary sinus floor elevation

Outcome Measures

Primary Outcomes (1)

• Various complications

  the rate of Implant survival, swelling, pain, etc.

  From having a tooth implant to one year after wearing the dentures

Secondary Outcomes (1)

• marginal bone resorption

  one year

Other Outcomes (1)

• Patient satisfaction

  From having a tooth implant to one year after wearing the dentures

Study Arms (1)

transcrestal sinus floor elevation

EXPERIMENTAL

Device: short implants (L=6.3mm); Procedure: short implants (L=8mm); Device: conventional implants (L=9mm)

Interventions

short implants (L=6.3mm) DEVICE

Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation

transcrestal sinus floor elevation

short implants (L=8mm) PROCEDURE

Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation

transcrestal sinus floor elevation

conventional implants (L=9mm) DEVICE

conventional implants (L=9mm) in the posterior maxillary region for dental restoration

transcrestal sinus floor elevation

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
• Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
• They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.

You may not qualify if:

• horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
• excessive tobacco use (more than 10 cigarettes per day)
• severe liver and kidney diseases
• history of radiotherapy and chemotherapy in the head and neck region
• uncontrolled diabetes
• active periodontal disease
• oral mucosal diseases in the treatment area or poor oral hygiene,
• PI \> 70%

Sponsors & Collaborators

• Linhu Wang: lead
• Dentsply Sirona Implants and Consumables: collaborator

Study Sites (1)

No. 26, Shengli Street, Jiang'an District, Wuhan City, Hubei Province, China

Wuhan, Hubei, 422202, China

Location

MeSH Terms

Conditions

Anodontia

Condition Hierarchy (Ancestors)

Tooth Abnormalities; Stomatognathic System Abnormalities; Stomatognathic Diseases; Tooth Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

lin hu Wang, Doctoral

CONTACT

+8618086060633; 316036445@qq.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Medical professor

Study Record Dates

• First Submitted: November 22, 2025
• First Posted: December 9, 2025
• Study Start: December 10, 2025
• Primary Completion (Estimated): June 30, 2027
• Study Completion (Estimated): July 30, 2028
• Last Updated: December 16, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, ICF, CSR

Locations

CN (1)